Rigel Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $110.4M
Liabilities Breakdown FY2020
Total Liabilities: $76.4M
Asset Breakdown
Total Assets: $110.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $30.4M | 27.5% |
| Accounts Receivable | $16.0M | 14.5% |
| Inventory | $1.6M | 1.5% |
| Property, Plant & Equipment | $2.7M | 2.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $59.7M | 54.1% |
Liabilities Breakdown
Total Liabilities: $76.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.7M | 4.9% |
| Long-Term Debt | $20.0M | 26.2% |
| Other Liabilities | $52.6M | 69.0% |